| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Product Name | Elagolix sodium |
|---|
| Description | Elagolix sodium is a human GnRH (Gonadotropin-Releasing Hormone) receptor antagonist with an IC50 and Ki of 0.25 and 3.7 nM, respectively. Elagolix alters the level of pituitary GnRH suppression and, as a result, titrating circulating estrogen levels. MW: 653.57. Purity ≥98% by HPLC |
|---|
| Size | 5 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | Sodium (R)-4-((2-(5-(2-fluoro-3-methoxyphenyl)-3-(2-fluoro-6-(trifluoromethyl)benzyl)-4-methyl-2,6-dioxo-2,3-dihydropyrimidin-1(6H)-yl)-1-phenylethyl)amino)butanoate; NBI56418 |
|---|
| Gene, Accession, CAS # | CAS: 832720-36-2 |
|---|
| Catalog # | B2112-5 |
|---|
| Price | |
|---|
| Order / More Info | Elagolix sodium from BIOVISION, INC. |
|---|
| Product Specific References | n/a |
|---|
| 產(chǎn)品資料 |
|
|